Abstract
The candidate tumour suppressor gene, LUCA-15, maps to the lung cancer tumour suppressor locus 3p21.3. Overexpression of an alternative RNA splice variant of LUCA-15 has been shown to retard human Jurkat T cell proliferation and to accelerate CD95-mediated apoptosis. An antisense cDNA to the 3′-UTR of this splice variant was able to suppress CD95-mediated apoptosis. Here, we report that overexpression of LUCA-15 itself suppresses CD95-mediated apoptosis in Jurkat cells. This suppression occurs prior to the final execution stage of the CD95 signalling pathway, and is associated with up-regulation of the apoptosis inhibitory protein Bcl-2. LUCA-15 overexpression is also able to inhibit apoptosis induced by the protein kinase inhibitor staurosporine, but is not able to significantly suppress apoptosis mediated by the topoisomerase II inhibitor etoposide. These findings suggest that LUCA-15 is a selective inhibitor of cell death, and confirm the importance of the LUCA-15 genetic locus in the control of apoptosis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Aravind L, Koonin EV . 1999 Trends Biochem. Sci. 24: 342–344
Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB . 1993 Cell 74: 597–608
Chung GT, Sundaresan V, Hasleton P, Rudd R, Taylor R, Rabbitts PH . 1995 Oncogene 11: 2591–2598
Daigo Y, Nishiwaki T, Kawasoe T, Tamari M, Tsuchiya E, Nakamura Y . 1999 Cancer Res. 59: 1966–1972
Daly MC, Xiang RH, Buchhagen D, Hensel CH, Garcia DK, Killary AM, Minna JD, Naylor SL . 1993 Oncogene 8: 1721–1729
Dole M, Nunez G, Merchant AK, Maybaum J, Rode CK, Bloch CA, Castle VP . 1994 Cancer Res. 54: 3253–3259
Drabkin HA, West JD, Hotfilder M, Heng YM, Erickson P, Calvo R, Dalmau J, Gemmill RM, Sablitzky F . 1999 Oncogene 18: 2589–2597
Frederick A, Rolfe M, Chiu MI . 1998 Oncogene 16: 153–165
Gazdar AF, Bader S, Hung J, Kishimoto Y, Sekido Y, Sugio K, Virmani A, Fleming J, Carbone DP, Minna JD . 1994 Cold Spring Harb. Symp. Quant. Biol. 59: 565–572
Gray DA, Inazawa J, Gupta K, Wong A, Ueda R, Takahashi T . 1995 Oncogene 10: 2179–2183
Hakem R, Hakem A, Duncan GS, Henderson JT, Woo M, Soengas MS, Elia A, de la Pompa JL, Kagi D, Khoo W, Potter J, Yoshida R, Kaufman SA, Lowe SW, Penninger JM, Mak TW . 1998 Cell 94: 339–352
Imreh S, Kost-Alimova M, Kholodnyuk I, Yang Y, Szeles A, Kiss H, Liu Y, Foster K, Zabarovsky E, Stanbridge E, Klein G . 1997 Genes Chrom. Cancer 20: 224–233
Inoue A, Takahashi KP, Kimura M, Watanabe T, Morisawa S . 1996 Nucleic Acids Res. 24: 2990–2997
Jackers P, Minoletti F, Belotti D, Clausse N, Sozzi G, Sobel ME, Castronovo V . 1996 Oncogene 13: 495–503
Jensen DE, Proctor M, Marquis ST, Gardner HP, Ha SI, Chodosh LA, Ishov AM, Tommerup N, Vissing H, Sekido Y, Minna J, Borodovsky A, Schultz DC, Wilkinson KD, Maul GG, Barlev N, Berger SL, Prendergast GC, Rauscher III FJ . 1998 Oncogene 16: 1097–1112
Johnson DE, Gastman BR, Wieckowski E, Wang GQ, Amoscato A, Delach SM, Rabinowich H . 2000 Cancer Res. 60: 1818–1823
Kamesaki S, Kamesaki H, Jorgensen TJ, Tanizawa A, Pommier Y, Cossman J . 1993 Cancer Res. 53: 4251–4256
Kashuba VI, Gizatullin RZ, Protopopov AI, Allikmets R, Korolev S, Li J, Boldog F, Tory K, Zabarovska V, Marcsek Z, Sumegi J, Klein G, Zabarovsky ER, Kisselev L . 1997 FEBS Lett. 419: 181–185
Kashuba VI, Szeles A, Allikmets R, Nilsson AS, Bergerheim US, Modi W, Grafodatsky A, Dean M, Stanbridge EJ, Winberg G, Klein G, Zabarovsky ER . 1995 Cancer Genet. Cytogenet. 81: 144–150
Kholodnyuk I, Kost-Alimova M, Kashuba V, Gizatulin R, Szeles A, Stanbridge EJ, Zabarovsky ER, Klein G, Imreh S . 1997 Genes Chromo. Cancer 18: 200–211
Kok K, Naylor SL, Buys CH . 1997 Adv. Cancer Res. 71: 27–92
Kok K, van den Berg A, Veldhuis PM, van der Veen AY, Franke M, Schoenmakers EF, Hulsbeek MM, van der Hout AH, de Leij L, van de Ven W, Buys CHCM . 1994 Cancer Res. 54: 4183–4187
Latif F, Duh FM, Bader S, Sekido Y, Li H, Geil L, Zbar B, Minna JD, Lerman MI . 1997 Hum. Genet. 99: 334–341
Li H, Zhu H, Xu CJ, Yuan J . 1998 Cell 94: 491–501
Lock RB, Stribinskiene L . 1996 Cancer Res. 56: 4006–4012
Luo X, Budihardjo I, Zou H, Slaughter C, Wang X . 1998 Cell 94: 481–490
Miyashita T, Reed JC . 1993 Blood 81: 151–157
Oh JJ, Grosshans DR, Wong SG, Slamon DJ . 1999 Nucleic Acids Res. 27: 4008–4017
Osheroff N . 1989 Biochemistry 28: 6157–6160
Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH, Peter ME . 1998 EMBO J. 17: 1675–1687
Sekido Y, Ahmadian M, Wistuba II, Latif F, Bader S, Wei MH, Duh FM, Gazdar AF, Lerman MI, Minna JD . 1998 Oncogene 16: 3151–3157
Sekido Y, Bader S, Latif F, Chen JY, Duh FM, Wei MH, Albanesi JP, Lee CC, Lerman MI, Minna JD . 1996 Proc. Natl. Acad. Sci. USA 93: 4120–4125
Shaham S, Horvitz HR . 1996 Cell 86: 201–208
Shriver SP, Shriver MD, Tirpak DL, Bloch LM, Hunt JD, Ferrell RE, Siegfried JM . 1998 Mutat Res. 406: 9–23
Sithanandam G, Latif F, Duh FM, Bernal R, Smola U, Li H, Kuzmin I, Wixler V, Geil L, Shrestha S . 1996 Mol. Cell. Biol. 16: 868–876
Slee EA, Keogh SA, Martin SJ . 2000 Cell Death Differ. 7: 556–565
Strasser A, Harris AW, Jacks T, Cory S . 1994 Cell 79: 329–339
Sutherland LC, Edwards SE, Cable HC, Poirier GG, Miller BA, Cooper CS, Williams GT . 2000 Oncogene 19: 3774–3781
Sutherland LC, Williams GT . 1997 J. Immunol. Methods 207: 179–183
Szeles A, Yang Y, Sandlund AM, Kholodnyuk I, Kiss H, Kost-Alimova M, Zabarovsky ER, Stanbridge E, Klein G, Imreh S . 1997 Genes Chromosomes Cancer 20: 329–336
Tamaoki T, Nomoto H, Takahashi I, Kato Y, Morimoto M, Tomita F . 1986 Biochem. Biophys. Res. Comm. 135: 397–402
Tang D, Lahti JM, Kidd VJ . 2000 J. Biol. Chem. 275: 9303–9307
Timmer T, Terpstra P, van den Berg A, Veldhuis PM, Ter Elst A, Voutsinas G, Hulsbeek MM, Draaijers TG, Looman MW, Kok K, Naylor SL, Buys CH . 1999 Eur. J. Hum. Genet. 7: 478–486
Todd MC, Xiang RH, Garcia DK, Kerbacher KE, Moore SL, Hensel CH, Liu P, Siciliano MJ, Kok K, van den Berg A, Veldhuis P, Buys CH, Killary AM, Naylor SL . 1996 Oncogene 13: 2387–2396
Uchida K, Yoshimura A, Inazawa J, Yanagisawa K, Osada H, Masuda A, Saito T, Takahashi T, Miyajima A . 1997 Cytogenet. Cell Genet. 78: 209–212
Wang L, Miura M, Bergeron L, Zhu H, Yuan J . 1994 Cell 78: 739–750
Wei MH, Latif F, Bader S, Kashuba V, Chen JY, Duh FM, Sekido Y, Lee CC, Geil L, Kuzmin I, Zabarovsky E, Klein G, Zbar B, Minna JD, Lerman MI . 1996 Cancer Res. 56: 1487–1492
Wyllie AH . 1997 Eur. J. Cell. Biol. 73: 189–197
Yamakawa K, Takahashi T, Horio Y, Murata Y, Takahashi E, Hibi K, Yokoyama S, Ueda R, Nakamura Y . 1993 Oncogene 8: 327–330
Yoshida H, Kong YY, Yoshida R, Elia AJ, Hakem A, Hakem R, Penninger JM, Mak TW . 1998 Cell 94: 739–750
Acknowledgements
The authors thank Thomas Rothstein for useful advice and critical reading of the manuscript, Ann Stanley for densitometric analysis, and Marty Hansell for graphical assistance. Funding was provided by a PennState Geisinger Cancer Center Research Grant (to LC Sutherland), Contract No. NO1-CO-56000 from the National Cancer Institute, National Institutes of Health (to M Lerman), and the National Institutes of Health DK46778 and M01 RR10732, and the Four Diamonds Fund (to BA Miller). The content of the publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sutherland, L., Lerman, M., Williams, G. et al. LUCA-15 suppresses CD95-mediated apoptosis in Jurkat T cells. Oncogene 20, 2713–2719 (2001). https://doi.org/10.1038/sj.onc.1204371
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204371
Keywords
This article is cited by
-
Differential downregulation of Rbm5 and Rbm10 during skeletal and cardiac differentiation
In Vitro Cellular & Developmental Biology - Animal (2014)
-
Tumor suppressor gene RBM5 delivered by attenuated Salmonella inhibits lung adenocarcinoma through diverse apoptotic signaling pathways
World Journal of Surgical Oncology (2013)
-
Suppressor of cytokine signaling 1 blocks mitosis in human melanoma cells
Cellular and Molecular Life Sciences (2013)
-
3p21.3 tumor suppressor gene RBM5 inhibits growth of human prostate cancer PC-3 cells through apoptosis
World Journal of Surgical Oncology (2012)
-
The tumor suppressor gene RBM5 inhibits lung adenocarcinoma cell growth and induces apoptosis
World Journal of Surgical Oncology (2012)